# A Dosage-dependent Manner of Botulinum Toxin Type A on the Prevention of Postoperative Scars of Various Anatomic Regions of the Body

> **NCT06349733** · EARLY_PHASE1 · COMPLETED · sponsor: **Qilu Hospital of Shandong University** · enrollment: 50 (actual)

## Conditions studied

- Scar

## Interventions

- **DRUG:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT06349733
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-23
- **Primary completion:** 2023-10-01
- **Final completion:** 2024-03-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06349733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06349733, "A Dosage-dependent Manner of Botulinum Toxin Type A on the Prevention of Postoperative Scars of Various Anatomic Regions of the Body". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06349733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*